Rheingold, Valet, Rheingold, Shkolnik & McCartney

Rheingold, Valet, Rheingold, Shkolnik & McCartney was a prominent New York-based law firm specializing in medical malpractice, personal injury, and mass tort litigation. The firm was widely recognized for its leadership in pharmaceutical and medical device litigation, representing plaintiffs in high-profile cases against major life science companies. Their work involved landmark settlements related to drugs such as Vioxx, Fen-Phen, and Rezulin, as well as defective medical implants. While not a biotechnology developer, the firm played a significant role in the healthcare ecosystem by litigating product liability and drug safety issues. The practice has since evolved into Rheingold Giuffra Ruffo & Plotkin LLP following various partnership reorganizations.